Michael Mina M.D., Ph.D. is an accomplished industry leader with extensive expertise in infectious diseases, molecular diagnostics, and public health.
Most recently, Dr. Mina led the U.S. government’s Home Test to Treat program, first announced by President Biden and funded through the NIH, the program was a nationwide effort to connect home diagnostics to telemedicine treatment in conjunction with eMed Digital Healthcare, where he served as Chief Scientific and Medical Officer. He has advised, led or served on the board for many of the leading companies in the diagnostic and consumer health spaces, including 3M, Walgreens, C2Sense, Quantum-SI, CorDx, Vital Bio and ImmuneID.
Prior to joining industry, Dr. Mina held multiple faculty positions in academic medicine. He was a professor of Epidemiology and of Immunology & Infectious Diseases at the Harvard T.H. Chan School of Public Health, where his research focused on highly multiplexed immunomics for public health and medicine. He was also a professor in the Department of Pathology at Harvard Medical School and Associate Director of Molecular Virology at Brigham and Women’s Hospital and helped create and support major nationwide testing efforts towards the COVID-19 response, including as medical director of the Broad Institute COVID-19 testing platform that served much of the Eastern seaboard. His research has received international recognition and was awarded an NIH Directors Early Independence Award and was highlighted as a Global Progress Maker by The Economist. He routinely advises federal and international governments as well as large and small corporations on technologies towards public health.
Dr. Mina received his M.D. and Ph.D. in the NIH Medical Scientist Training Program in infectious diseases, immunology and mathematics at Emory University. He completed his residency in pathology at Harvard Medical School and post-doctoral research in mathematics of infectious diseases at Princeton University and in Genetics at Harvard University. He graduated with
bachelor’s degrees in engineering and global health from Dartmouth College and, amongst other recognitions, was invited to receive an honorary doctorate for his work combating the pandemic.
Back to Our Team